During the past decade, CCOP - Bay Area Tumor Institute conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 96 clinical trials were completed, i.e. on average, 157.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 31 clinical trials were completed. i.e. 129.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Bay Area Tumor Institute" #1 sponsor was "SWOG Cancer Research Network" with 101 trials, followed by "National Cancer Institute (NCI)" with 67 trials sponsored, "Radiation Therapy Oncology Group" with 56 trials sponsored, "Alliance for Clinical Trials in Oncology" with 45 trials sponsored and "NSABP Foundation Inc" with 45 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Bay Area Tumor Institute" #1 collaborator was "National Cancer Institute (NCI)" with 247 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "SWOG Cancer Research Network" with 22 trials as a collaborator, "Cancer and Leukemia Group B" with 20 trials as a collaborator and "Eastern Cooperative Oncology Group" with 15 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Bay Area Tumor Institute" are "Breast Cancer" (46 trials), "Lung Cancer" (35 trials), "Head and Neck Cancer" (17 trials), "Colorectal Cancer" (16 trials) and "Prostate Cancer" (15 trials). Many other conditions were trialed in "CCOP - Bay Area Tumor Institute" in a lesser frequency.

Most popular intervention types in "CCOP - Bay Area Tumor Institute" are "Drug" (260 trials), "Other" (97 trials), "Radiation" (92 trials), "Biological" (90 trials) and "Procedure" (64 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (55 trials), "Laboratory Biomarker Analysis" (44 trials), "cisplatin" (34 trials), "Quality-of-Life Assessment" (28 trials) and "paclitaxel" (28 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Bay Area Tumor Institute" are 236 trials for "All" genders, 68 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Bay Area Tumor Institute". undefined are not yet recruiting, 24 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 204 completed trials in CCOP - Bay Area Tumor Institute, 1 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Bay Area Tumor Institute, 16 "Phase 1" clinical trials were conducted, 146 "Phase 2" clinical trials and 153 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".